ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664217 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664217; 2) Community: the network communities that were significantly associated with the response to NSC 664217; 3) Molecule: the relationships between components within communities and NSC 664217; 4) MDR: the compounds that were significantly associated with the NSC 664217.

NSC Compound Enrichment Correlation
NSC 722854 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline 0.0430505868034761 0.31562546
NSC 726267 Null 0.0430505868034761 0.013889845
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0430505868034761 0.37424868
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0430505868034761 0.19912956
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0430505868034761 0.33743054
NSC 740 Methotrexate 0.0430505868034761 0.50709028
NSC 746540 Null 0.0430505868034761 0.40964622
NSC 747461 Null 0.0430505868034761 -0.014046133
NSC 748712 Null 0.0430505868034761 0.041143643
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0430505868034761 0.39651526
Total:121  Current:107    [First] [Prev] [Next] [Last]